DealBook: Seeking the Right Chemistry, Drug Makers Hunt for Mergers

Tuesday, April 22, 2014 - 23:00 in Psychology & Sociology

The offer for Allergan by William A. Ackman and Valeant Pharmaceuticals marks an unusual pairing of activist investor and corporate buyer that could reshape the deal landscape.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net